Aurora Cannabis (ACB) Revenue Growth (3y) (2020 - 2025)
Aurora Cannabis (ACB) Revenue Growth (3y) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 2.84% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 4.19% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -4.46% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 15.52% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -2.00% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 24.66% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 2.94% |
| 10 | Aurora Cannabis | 1.11 Bn | 1.03 Bn | 21.72 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -11.12% |
| Sep 30, 2025 | -4.78% |
| Jun 30, 2025 | 21.64% |
| Mar 31, 2025 | 24.46% |
| Dec 31, 2024 | 9.52% |
| Sep 30, 2024 | 39.27% |
| Jun 30, 2024 | 48.82% |
| Mar 31, 2024 | 4.70% |
| Dec 31, 2023 | -3.06% |
| Sep 30, 2023 | 101.93% |
| Jun 30, 2023 | 81.24% |
| Dec 31, 2022 | 40.65% |
| Sep 30, 2022 | 10.08% |
| Jun 30, 2022 | 33.36% |
| Mar 31, 2022 | -6.67% |
| Dec 31, 2021 | 5.40% |
| Sep 30, 2021 | 28.13% |
| Jun 30, 2021 | -92.37% |
| Mar 31, 2021 | 50.68% |
| Dec 31, 2020 | 77.96% |